Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 300 shares at $50.00 ($15K) on 2020-02-05, disclosed to the SEC on 2020-02-07.
Scheduled sale ($15k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RGNX | SELL | 2022-08-03 | $75K | — | Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |